These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 11594707)
1. Is autologous bone marrow transplant (ABMT) and high-dose chemotherapy an approach that can rescue some children with advanced cancer disease? Rivera-Luna R; Olaya-Vargas A; Meza-Coria C; Cárdenas-Cardos R; Leal-Leal C; Amador-Zarco J Pediatr Hematol Oncol; 2001; 18(7):443-51. PubMed ID: 11594707 [TBL] [Abstract][Full Text] [Related]
2. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma. Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951 [TBL] [Abstract][Full Text] [Related]
3. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Schetelig J; Fetscher S; Reichle A; Berdel WE; Beguin Y; Brunet S; Caballero D; Majolino I; Hagberg H; Johnsen HE; Kimby E; Montserrat E; Stewart D; Copplestone A; Rösler W; Pavel J; Kingreen D; Siegert W Haematologica; 2003 Nov; 88(11):1272-8. PubMed ID: 14607756 [TBL] [Abstract][Full Text] [Related]
4. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma. Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281 [TBL] [Abstract][Full Text] [Related]
5. Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology. Spreafico F; Bisogno G; Collini P; Jenkner A; Gandola L; D'Angelo P; Casazza G; Piva L; Luksch R; Perotti D; Pession A; Fagioli F; Dallorso S Pediatr Blood Cancer; 2008 Jul; 51(1):23-8. PubMed ID: 18293386 [TBL] [Abstract][Full Text] [Related]
6. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas]. Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047 [TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome. Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050 [TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. Gururangan S; McLaughlin C; Quinn J; Rich J; Reardon D; Halperin EC; Herndon J; Fuchs H; George T; Provenzale J; Watral M; McLendon RE; Friedman A; Friedman HS; Kurtzberg J; Vredenbergh J; Martin PL J Clin Oncol; 2003 Jun; 21(11):2187-91. PubMed ID: 12775745 [TBL] [Abstract][Full Text] [Related]
9. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience. Avramova B; Jordanova M; Michailov G; Konstantinov D; Christosova I; Bobev D J BUON; 2006; 11(4):433-8. PubMed ID: 17309174 [TBL] [Abstract][Full Text] [Related]
10. Partially mismatched related donor bone marrow transplantation as salvage for patients with AML who failed autologous stem cell transplant. Godder KT; Mehta J; Chiang KY; Adams S; van Rhee F; Singhal S; Higgins-Smith K; O'Neal W; DeRienzo S; Henslee-Downey JP Bone Marrow Transplant; 2001 Dec; 28(11):1031-6. PubMed ID: 11781612 [TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941. Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292 [TBL] [Abstract][Full Text] [Related]
12. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome. Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918 [TBL] [Abstract][Full Text] [Related]
13. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases]. Zhou SY; Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou AP; Feng FY Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021 [TBL] [Abstract][Full Text] [Related]
14. Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit. Kurian S; Qazilbash M; Fay J; Wolff S; Herzig R; Hobbs G; Bunner P; Weisenborn R; Aya-Ay M; Lynch J; Ericson S Breast J; 2006; 12(6):531-5. PubMed ID: 17238982 [TBL] [Abstract][Full Text] [Related]
15. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response. Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350 [TBL] [Abstract][Full Text] [Related]
16. Dose intensification with autologous stem cell transplantation in relapsed and resistant Hodgkin's disease. Anselmo AP; Cavalieri E; Meloni G; Alimena G; Cantonetti M; Maurizi Enrici R; Tosti ME; Falchetto Osti M; Gianfelici V; Mandelli F Haematologica; 2002 May; 87(5):507-11. PubMed ID: 12010664 [TBL] [Abstract][Full Text] [Related]
17. Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results. Gaziev D; Galimberti M; Polchi P; Angelucci E; Giardini C; Baronciani D; Andreani M; Persini B; Erer B; Sodani P; Manna M; Nicolini G; Visani G; Lucarelli G; Bone Marrow Transplant; 2002 Jan; 29(1):1-8. PubMed ID: 11840137 [TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission. De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539 [TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma. Kremens B; Gruhn B; Klingebiel T; Hasan C; Laws HJ; Koscielniak E; Hero B; Selle B; Niemeyer C; Finckenstein FG; Schulz A; Wawer A; Zintl F; Graf N Bone Marrow Transplant; 2002 Dec; 30(12):893-8. PubMed ID: 12476282 [TBL] [Abstract][Full Text] [Related]
20. Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital. Campbell AD; Cohn SL; Reynolds M; Seshadri R; Morgan E; Geissler G; Rademaker A; Marymount M; Kalapurakal J; Haut PR; Duerst R; Kletzel M J Clin Oncol; 2004 Jul; 22(14):2885-90. PubMed ID: 15254057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]